Mehmet Emrah Selli (Mehmet E Selli)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Recombinant Human

Regulatory T Cells

Top Venues

Cancer discovery

Cancer immunology research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors. Cancer immunology research 12 (9) (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors. Cancer immunology research (2024)
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Mehmet Emrah Selli, Jack Landmann, Marina Terekhova, John Lattin, Amanda Heard, Yu-Sung Hsu, Tien-Ching Chang, Ju-Fang Chang, John M Warrington, Helen Ha, Natalie L Kingston, Graham D Hogg, Michael Joseph Slade, Melissa M Berrien-Elliott, Mark Foster, Samantha Kersting-Schadek, Agata Gruszczynska, David DeNardo, Todd A Fehniger, Maxim Artyomov, Nathan Singh
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction. Blood (2023)
Amanda Heard, Jack H Landmann, Ava R Hansen, Alkmini Papadopolou, Yu-Sung Hsu, Mehmet Emrah Selli, John M Warrington, John Lattin, Jufang Chang, Helen Ha, Martina Haug-Kroeper, Balraj Doray, Saar Gill, Marco Ruella, Katharina E Hayer, Matthew D Weitzman, Abby M Green, Regina Fluhrer, Nathan Singh
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19. Nature communications 13 (1) (2022)
Armin Ghobadi, Jack H Landmann, Alun Carter, Matthew L Cooper, Mehmet Emrah Selli, Jufang Chang, Matthew L Baker, Christopher A Miller, Francesca Ferraro, David Y Chen, Amanda M Smith, Taylor A LaValle, Eric J Duncavage, Justin Chou, Victor Tam, Joseph M Benoun, Jenny Nater, Nathalie Scholler, Francesca Milletti, Remus Vezan, Adrian Bot, John M Rossi, Nathan Singh
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies. Blood advances 6 (20) (2022)